Buy Prolopa from Canada

$62.95$127.95

In Prolopa, levodopa is the primary agent that crosses the blood-brain barrier to be converted into dopamine, essential for managing the motor symptoms of Parkinson’s disease. On the other hand, Benserazide blocks the enzyme that breaks down levodopa in the peripheral system (outside the brain), preventing its premature conversion before reaching the brain where it’s needed. This enhances the availability of levodopa for conversion into dopamine, effectively alleviating symptoms of rigidity, tremors, and bradykinesia associated with Parkinson’s disease.

- +
Compare
SKU: N/A Category:

Description

Prolopa is a combination medication composed of levodopa and benserazide, designed specifically to manage the symptoms of Parkinson’s disease and Parkinson-like symptoms that may occur with other neurological disorders. Levodopa acts as a precursor to dopamine, compensating for the diminished dopamine levels in the brains of those affected by Parkinson’s disease, while benserazide inhibits the breakdown of levodopa before it reaches the brain, maximizing its efficacy. This strategic combination ensures a more controlled and effective management of Parkinson’s symptoms.